中文 | English
Return
Total: 4278 , 1/428
Show Home Prev Next End page: GO
Author:( Tao XU)

1.Celecoxib inhibits proliferation of polycystic kidney cyst lining epithelial cells through blocking mitogen-activated protein kinase signal transduction pathways

Tao XU

Academic Journal of Second Military Medical University 1985;0(06):-

2.Contrastive Linguistics and Contrastive Language Teaching

Tao XU

Journal of Kunming Medical University 2013;(11):128-132

3.Analysis of urogenital Ureaplasma urealyticum infection and their drug tolerance

Qing WU ; Tao XU

International Journal of Laboratory Medicine 2008;29(5):412-413

4.New Channels and Transporters as Anti-malaria Drug Targets

Tao XU ; Huaimin ZHU

Chinese Journal of Parasitology and Parasitic Diseases 1997;0(05):-

5.Analysis of Labeled Items in Package Inserts of 51 Kinds of Ointment for External Use

Wen XU ; Liang TAO

China Pharmacy 2017;28(16):2286-2288

6.Analysis of development, safety and efficacy of percutaneous nephrolithotomy for management of upper urinary tract calculi in pediatric patients

Luping YU ; Tao XU

Journal of Peking University(Health Sciences) 2017;49(4):626-631

7.Application of Manual Stitching Technique for Digital Radiography in Total Knee Arthroplasty

Liang XU ; Tao QIN

Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2014;(4):456-458,459

8.Retrospective analysis and preventive strategies in the cesarean section operation incision infection of 29 cases

Hongying TAO ; Xu WANG

Chongqing Medicine 2015;(33):4663-4664,4670

9.Effect of Ghrelin on contractility of gastric smooth muscle in guinea pigs and the related mechanism

Yuan TAO ; Luo XU

Academic Journal of Second Military Medical University 1981;0(03):-

10.Investigation on Preparation Process of Xiaoyaosan Oral Liquid(Radix Bupleuri,Radix Angelicae Sinensis,etc.)

Jiansheng TAO ; Lianying XU ;

Chinese Traditional Patent Medicine 1992;0(11):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4278 , 1/428 Show Home Prev Next End page: GO